Reversal of Adrenergic Desensitization in Prenatally Stressed Rats by P38 Map Kinase Inhibitor, SB203580

被引:0
|
作者
Chen, Fangping [1 ]
Kan, Hong [1 ]
Xie, Sherry [1 ]
Beto, Robert J. [1 ]
Warden, Bradford E. [1 ]
Jain, Abnash C. [1 ]
Finkel, Mitchell S. [1 ,2 ]
机构
[1] W Virginia Univ, Morgantown, WV 26506 USA
[2] Louis A Johnson VA Med Ctr, Clarksburg, WV USA
来源
FASEB JOURNAL | 2008年 / 22卷
关键词
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
引用
收藏
页数:1
相关论文
共 50 条
  • [41] The p38 mitogen-activated protein kinase inhibitor SB203580 can antagonise P2X7 receptor-mediated responses.
    Michel, D
    Thompson, KM
    Humphrey, PPA
    BRITISH JOURNAL OF PHARMACOLOGY, 2001, 133 : U112 - U112
  • [42] Preclinical pharmacokinetics of SB-203580, a potent inhibitor of p38 mitogen-activated protein kinase
    Ward, KW
    Proksch, JW
    Azzarano, LM
    Mumaw, JA
    Roethke, TJ
    Stelman, GJ
    Walsh, MJ
    Zeigler, KS
    McSurdy-Freed, JE
    Kehler, JR
    Chokshi, J
    Levy, MA
    Smith, BR
    XENOBIOTICA, 2001, 31 (11) : 783 - 797
  • [43] Administration of the p38 MAPK inhibitor SB203580 affords brain protection with a wide therapeutic window against focal ischemic insult
    Piao, CS
    Kim, JB
    Han, PL
    Lee, JK
    JOURNAL OF NEUROSCIENCE RESEARCH, 2003, 73 (04) : 537 - 544
  • [44] Gene Expression Analysis to Evaluate the Effect of p38 Specific Inhibitor SB203580 on SEB-Induced Apoptosis Related Pathways
    Sondgeroth, Casey
    Hesse, Lisa
    Allbaugh, Alyssa
    Mendis, Chanaka
    Jett, Marti
    FASEB JOURNAL, 2013, 27
  • [45] The p38 MAPK inhibitor SB203580 blocks adenosine A1 receptor-induced attenuation of in vivo myocardial stunning
    Yoshimura, Y
    Kristo, G
    Keith, BJ
    Jahania, SA
    Mentzer, RM
    Lasley, RD
    CARDIOVASCULAR DRUGS AND THERAPY, 2004, 18 (06) : 433 - 440
  • [46] The immunophilin ligand FK506, but not the p38 kinase inhibitor SB203580, improves function of adult rat muscle reinnervated from transplants of embryonic neurons
    Grumbles, RM
    Casella, GTB
    Rudinsky, MJ
    Godfrey, S
    Wood, PM
    Thomas, CK
    NEUROSCIENCE, 2005, 130 (03) : 619 - 630
  • [47] SB203580, a p38 Inhibitor, Improved Cardiac Function but Worsened Lung Injury and Survival During Escherichia coli Pneumonia in Mice
    Su, Junwu
    Cui, Xizhong
    Li, Yan
    Mani, Haresh
    Ferreyra, Gabriela A.
    Danner, Robert L.
    Hsu, Lewis L.
    Fitz, Yvonne
    Eichacker, Peter Q.
    JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE, 2010, 68 (06): : 1317 - 1327
  • [48] The p38 MAPK Inhibitor SB203580 Blocks Adenosine A1 Receptor-Induced Attenuation of In Vivo Myocardial Stunning
    Yukihiro Yoshimura
    Gentian Kristo
    Byron J. Keith
    Salik A. Jahania
    Robert M. Mentzer
    Robert D. Lasley
    Cardiovascular Drugs and Therapy, 2004, 18 : 433 - 440
  • [49] Dynamics in the p38α MAP kinase-SB203580 complex observed by liquid-state NMR spectroscopy
    Honndorf, Valerie S.
    Coudevylle, Nicolas
    Laufer, Stefan
    Becker, Stefan
    Griesinger, Christian
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2008, 47 (19) : 3548 - 3551
  • [50] In vitro modeling of COPD inflammation and limitation of p38 inhibitor-SB203580
    Meng, Aihong
    Zhang, Xiaopeng
    Wu, Siyu
    Wu, Mingxia
    Li, Jing
    Yan, Xixin
    Kopec-Harding, Kamilla
    Wu, Jiakai
    INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2016, 11 : 909 - 917